Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeys

Neuropharmacology

Volumn 72, Issue , 2013, Pages 74-81

  Ferguson, Charmaine S ^a,b   Miksys, Sharon ^a,b   Palmour, Roberta M ^c,d   Tyndale, Rachel F ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Behavioural Sciences Foundation   (Canada)

Author keywords

Brain; CYP2B6; CYP2E1; Ethanol; Induction; Monkey; Nicotine

Indexed keywords

ALCOHOL; CYTOCHROME P450 2B6; CYTOCHROME P450 2E1; MESSENGER RNA; NICOTINE; SUCROSE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN LEVEL; BRAIN REGION; CAUDATE NUCLEUS; CEREBELLUM; CHLOROCEBUS; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME REGULATION; ENZYME SPECIFICITY; FRONTAL CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; SMOKING; THALAMUS; TISSUE DISTRIBUTION;

EID: 84884888870     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.04.022     Document Type: Article

References (32)

1. Benowitz, N.L., Jacob 3rd, P., 1990. Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. In: Wonnacott, S., Russell, M.A.H., Stolerman, I.P. (Eds.), Nicotine Psychopharmacology: Molecular, Cellular and Behavioral Aspects. Oxford University Press, Oxford, pp. 112-157.
2. Benowitz, N.L., Jacob 3rd, P., 1984. Daily intake of nicotine during cigarette smoking. Clin. Pharmacol. Ther. 35, 499-504. (Pubitemid 14133490)
3. Bobo, J.K.J., Husten, C.C., 2000. Sociocultural influences on smoking and drinking. Alcohol. Res. Health 24, 225-232.
4. Caro, A.A., Cederbaum, A.I., 2004. Oxidative stress, toxicology, and pharmacology of CYP2-. Annu. Rev. Pharmacol. Toxicol. 44, 27-42. (Pubitemid 38263832)
5. Ervin, F.R., Palmour, R.M., Young, S.N., Guzman-Flores, C., Juarez, J., 1990. Voluntary consumption of beverage alcohol by vervet monkeys: population screening, descriptive behavior and biochemical measures. Pharmacol. Biochem. Behav. 36, 367-373. (Pubitemid 20189797)
6. Ferguson, C.S., Miksys, S., Palmour, R., Tyndale, R.F., 2011. Independent and combined effects of ethanol self-administration and nicotine treatment on hepatic CYP2-1 in African green monkeys. Drug Metab. Dispos. 39, 2233-2241.
7. Ferguson, C.S., Miksys, S., Palmour, R.M., Tyndale, R.F., 2012. Differential effects of nicotine treatment and ethanol self-administration on CYP2A6, CYP2B6 and nicotine pharmacokinetics in African green monkeys. J. Pharmacol. Exp. Ther. 343, 628-637.
8. Ferguson, C.S., Tyndale, R.F., 2011. Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol. Sci. 32, 708-714.
9. Howard, L.A., Miksys, S., Hoffmann, E., Mash, D., Tyndale, R.F., 2003. Brain CYP2-1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. Br. J. Pharmacol. 138, 1376-1386. (Pubitemid 36543136)
10. Joshi, M., Tyndale, R.F., 2006a. Regional and cellular distribution of CYP2-1 in monkey brain and its induction by chronic nicotine. Neuropharmacology 50, 568-575.
11. Joshi, M., Tyndale, R.F., 2006b. Induction and recovery time course of rat brain CYP2-1 after nicotine treatment. Drug Metab. Dispos. 34, 647-652.
12. Kaut, O., Schmitt, I., Wüllner, U., 2012. Genome-scale methylation analysis of Parkinson's disease patients' brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2-1. Neurogenetics 13, 87-91.
13. Kezic, S., Calkoen, F., Wenker, M.A.M., Jacobs, J.J.L., Verberk, M.M., 2006. Genetic polymorphism of metabolic enzymes modifies the risk of chronic solventinduced encephalopathy. Toxicol. Ind. Health 22, 281-289. (Pubitemid 44367559)
14. Khokhar, J.Y., Tyndale, R.F., 2011. Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects. Neuropsychopharmacology 36, 692-700.
15. Khokhar, J.Y., Tyndale, R.F., 2012. Rat brain CYP2B-enzymatic activation of chlorpyrifos to the oxon mediates cholinergic neurotoxicity. Toxicol. Sci. 126, 325-335.
16. Koop, D.R., 1992. Oxidative and reductive metabolism by cytochrome P450 2-1. FASEB J. 6, 724-730.
17. Lee, A.M., Miksys, S., Palmour, R., Tyndale, R.F., 2006. CYP2B6 is expressed in African green monkey brain and is induced by chronic nicotine treatment. Neuropharmacology 50, 441-450. (Pubitemid 43209040)
18. Lerman, C., Shields, P.G., Wileyto, E.P., Audrain, J., Pinto, A., Hawk, L., Krishnan, S., Niaura, R., Epstein, L., 2002. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics and genomics 12, 627-634. (Pubitemid 36005672)
19. Lieber, C.S., 1999. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998) e a review. Alcohol. Clin. Exp. Res. 23, 991-1007. (Pubitemid 29283494)
20. Mann, A., Miksys, S., Lee, A., Mash, D.C., Tyndale, R.F., 2008. Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment. Neuropharmacology 55, 1147-1155.
21. Miksys, S., Hoffmann, E., Tyndale, R.F., 2000. Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment. Biochem. Pharmacol. 59, 1501-1511. (Pubitemid 30229882)
22. Miksys, S., Lerman, C., Shields, P.G., Mash, D.C., Tyndale, R.F., 2003. Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology 45, 122-132. (Pubitemid 36700458)
23. Miksys, S., Rao, Y., Hoffmann, E., Mash, D.C., Tyndale, R.F., 2002. Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. J. Neurochem. 82, 1376-1387.
24. Miksys, S., Tyndale, R.F., 2009. Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition. Neuropsychopharmacology 34, 634-640.
25. Miksys, S., Tyndale, R.F., 2012. Cytochrome P450-mediated drug metabolism in the brain. J. Psychiatry Neurosci. 37, 120-133.
26. Mo, S.L., Liu, Y.H., Duan, W., Wei, M.Q., Kanwar, J.R., Zhou, S.F., 2009. Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6. Curr. Drug Metab. 10, 730-753.
27. Palmour, R.M., Ervin, F.R., Baker, G.B., Young, S.N., 1998. An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys. Psychopharmacology (Berl.) 136, 1-7. (Pubitemid 28097514)
28. Renaud, H.J., Cui, J.Y., Khan, M., Klaassen, C.D., 2011. Tissue distribution and genderdivergent expression of 78 cytochrome P450 mRNAs in mice. Toxicol. Sci. 124, 261-277.
29. Shiffman, S., Balabanis, M., 1995. Association between alcohol and tobacco. In: Fertig, J.B., Allen, J.P. (Eds.), Alcohol and Tobacco: From Basic Science to Clinical Practice (National Institute on Alcohol Abuse and Alcoholism Research Monograph No. 30). United States Government Printing Office, Washington, pp. 17-36.
30. Smith, T.D., Bhatnagar, K.P., 2004. Microsmatic primates: reconsidering how and when size matters. Anat. Rec. B. New Anat. 279, 24-31. (Pubitemid 39062519)
31. Upadhya, S.C., Chinta, S.J., Pai, H.V., Boyd, M.R., Ravindranath, V., 2002. Toxicological consequences of differential regulation of cytochrome p450 isoforms in rat brain regions by phenobarbital. Arch. Biochem. Biophys. 399, 56-65. (Pubitemid 34848310)
32. Zhong, Y., Dong, G., Luo, H., Cao, J., Wang, C., Wu, J., et al., 2012. Induction of brain CYP2-1 by chronic ethanol treatment and related oxidative stress in hippocampus, cerebellum, and brainstem. Toxicology 302, 275-284.